Table 4 Water consumption and physical activity for study participants reported as Mean ± SE (Range).
From: Acid-base balance and hydration status following consumption of mineral-based alkaline bottled water
Group | Pre-Treatment Period | Treatment Period | Post-Treatment Period | |||
|---|---|---|---|---|---|---|
†SRWC (L/day) | ‡Daily PA (mins/day) | SRWC (L/day) | Daily PA (mins/day) | SRWC (L/day) | Daily PA (mins/day) | |
Control | ||||||
Women (n = 12) | 2.5 ± 0.2 (1.7 - 4.8) | 82 ± 9 (20 - 153) | 2.4 ± 0.3 (1.2 - 5.0) | 77 ± 12 (16 - 173) | 2.2 ± 0.2 (1.3 - 4.7) | 83 ± 12 (27 - 156) |
Men (n = 7) | 2.4 ± 0.4 (1.2 - 4.2) | 92 ± 5 (78 - 109) | 2.2 ± 0.4 (1.0 - 3.8) | 82 ± 11 (60 - 135) | 2.3 ± 0.5 (1.0 - 3.8) | 74 ± 10 (45 - 106) |
Entire Group (n = 19) | 2.5 ± 0.2 (1.2 - 4.8) | 85 ± 8 (20 - 153) | 2.4 ± 0.3 (1.0 - 5.0) | 78 ± 8 (16 - 173) | 2.2 ± 0.3 (1.0 - 4.7) | 80 ± 8 (27 - 156) |
Experimental | ||||||
Women (n = 13) | 2.0 ± 0.2 (1.0 - 4.1) | 74 ± 9 (12 - 128) | 1.9 ± 0.2 (1.0 - 4.0) | 58 ± 6 (29 - 93) | 1.7 ± 0.2 (1.0 - 3.0) | 74 ± 10 (40 - 166) |
Men (n = 6) | 3.1 ± 0.2 (2.1 - 4.0) | 105 ± 15 (41 - 170) | 2.8 ± 0.5 (1.1 - 5.8) | 91 ± 15 (15 - 127) | 3.4 ± 0.4 (2.0 - 5.8) | 92 ± 16 (47 - 145) |
Entire Group (n = 19) | 2.4 ± 0.2 (1.0 - 4.1) | 85 ± 6 (12 - 170) | 2.2 ± 0.2 (1.0 - 5.8) | 70 ± 8 (15 - 127) | 2.3 ± 0.2 (1.0 - 5.8) | 81 ± 8 (40 - 166) |